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MinireviewNeurotrophins:
To Cleave or Not to Cleave
peptide, sites for glycosylation, and pairs of basic amino
acids that are recognized by processing enzymes. The
calcium-dependent serine protease furin and other
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members of the prohormone convertase family cleaveDepartments of Cell Biology, Physiology,
each of the neurotrophins at a dibasic cleavage siteand Neuroscience
in the middle of the precursor protein, releasing theNew York University School of Medicine
biologically active 12–14 kDa C-terminal product (Sei-New York, New York 10016
dah et al., 1996). Remarkably, the pro-domain se-2 Department of Physiology and Biophysics
quences of individual neurotrophins are highly con-University of Washington
served among vertebrate species, suggesting that theseSeattle, Washington 98195
sequences may have important functions. For instance,
a stretch of pro-domain sequence in zebrafish and hu-
man BDNF exhibits higher identity than the matureThe family of neurotrophic factors known as neuro-
BDNF sequence of these species. Several regions in thetrophins has yielded a series of surprises, both with
pro-domains have been proposed to assist in properregard to the broad extent of their functional roles and
folding and secretion of neurotrophins (Suter et al., 1991)the remarkable complexity of their signaling mecha-
or possess biological activities (Dicou et al., 1997). How-nisms. The recent discovery that a neurotrophin pre-
ever, noting that unprocessed proneurotrophins oftencursor protein and its proteolytically processed prod-
represent abundant forms of secreted neurotrophin, Leeucts may differentially activate pro- and antiapoptotic
et al. (2001) initiated studies that provide striking newcellular responses, through preferential activation of
insight into the possible functions of conserved pro-Trk or p75 receptors, promises to unveil yet another
domain sequences.level of regulatory complexity.
To facilitate isolation of intact proNGF, Lee and col-
leagues produced a furin-resistant proNGF protein byNeurotrophins produce a plethora of effects ranging
changing two conserved arginine residues to alaninefrom neuronal survival to activity-dependent neuronal
(Lee et al., 2001) and isolated sufficient quantities forplasticity. Now a new mechanism has been reported
receptor binding and functional analyses. Even the mu-that forces a reexamination of existing models of neuro-
tated proNGF remained sensitive to cleavage by varioustrophin action and raises interesting implications on the
extracellular proteases, increasing the difficulty of isola-regulation of other growth factor families.
tion and further analysis.It has been known for decades that NGF, BDNF, NT-3,
Binding studies with the NGF receptors, the TrkA re-and NT-4/5 are made first as precursor proteins, which
ceptor tyrosine kinase and p75NTR, yielded a surprisingthen are cleaved intracellularly to mature proteins of
result. ProNGF bound to p75NTR with a higher affinity118–120 amino acids. The mature proteins associate
than the mature NGF (Figure 1). Competition bindingtightly as biologically active homodimers. Cellular re-
assays indicated that proNGF exhibited an equilibriumsponses to these26 kDa neurotrophin dimers are me-
binding constant for p75NTR of 1010 M, some five timesdiated by the p75 neurotrophin receptor (p75NTR), a mem-
stronger than for mature NGF, while proNGF bound TrkAber of the NGF/TNF receptor superfamily, which
receptors much less strongly than mature NGF. Curi-nonselectively binds all neurotrophins, as well as TrkA,
ously, these comparisons had never been made pre-TrkB, and TrkC receptors, receptor tyrosine kinases that
viously, although the reduced affinity of proNGF for TrkA
each selectively bind only a subset of the neurotrophins.
is consistent with an earlier report that proNGF has only
Although characterization of p75NTR preceded discovery
weak biological activity (Edwards et al., 1988). The
of the Trk receptors by half a decade, elucidation of the greater affinity of proNGF for p75NTR was reflected in
function and signaling mechanism of p75NTR has not kept greater potency of proNGF for activation of a p75-medi-
pace with the Trk receptors. Confusingly, although ated cellular response—induction of apoptosis of smooth
prominent developmental defects in p75NTR knockout muscle cells. Although the biological significance of this
mice demonstrate the functional potency of this recep- activity is unclear, increased proapoptotic activity of
tor, p75-mediated cellular responses to purified neuro- proNGF compared to mature NGF was somewhat
trophins are generally weak and are typically observed greater than might be predicted solely from the greater
only at neurotrophin concentrations greater than those affinity of binding of proNGF, suggesting that proNGF
known to occur in vivo. Furthermore, these responses might be a more effective agonist for p75NTR activation.
have proven to be hard to reproduce from laboratory to These findings immediately address several nagging
laboratory. problems. In previous studies, p75 signaling pathways
A possible resolution of these dilemmas has arisen were only weakly activated by neurotrophins. For exam-
from functional characterization of neurotrophin precur- ple, although numerous studies have revealed the ca-
sor proteins. All the neurotrophins are initially produced pacity of p75 receptor activation to elicit apoptotic cell
as 30–35 kDa precursor proteins containing a signal death (for example, Bamji et al., 1998; Yoon et al., 1998),
the high concentration of neurotrophins required to elicit
this effect was worrisome. Different preparations of neu-3 Correspondence: chao@saturn.med.nyu.edu (M.V.C.), mab@
u.washington.edu (M.B.) rotrophins, including those from commercial sources,
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rotrophin binding sites by neurotrophin receptors is
functionally critical. The principal domains in the Trk
receptors that determine affinity and specificity of bind-
ing are the immunoglobulin-C2 domains. For p75, bind-
ing is facilitated through the four negatively charged
cysteine-rich repeats. There is no sequence similarity
between the neurotrophin binding domains of p75NTR
and Trk receptors. Extensive structural studies and mu-
tagenesis have been employed to map the contacts
responsible for the binding interactions of neurotrophins
with p75NTR and Trk receptors. It will be of great interest
to see what structure the proneurotrophin adopts.
Proneurotrophins apparently are secreted as oligomers
that are assumed to be dimeric, like the mature neuro-
trophins. However, the possibility that these oligomers
might be trimeric (like ligands for most other members of
the NGF/TNF receptor superfamily) or higher aggregates
has not been excluded. Further, it will be important toFigure 1. Proposed Model of the Action of Proneurotrophin versus
Mature Neurotrophin upon Their Receptors, p75NTR, a Death Domain know whether the prodomain of NGF provides additional
Containing Receptor, and Trk Receptor Tyrosine Kinases binding contacts with p75NTR or whether it alters the
Lee et al. (2001) established that proNGF binds to the p75 receptor conformation of the domain representing the mature
with a higher affinity than mature NGF, leading to increased death form of NGF.
signaling. Binding of mature NGF to Trk receptors leads to a survival The complexity of functional interactions between
outcome. Therefore, proNGF may dictate apoptotic versus survival
p75NTR and Trk neurotrophin receptors arguably exceedsoutcomes through differential receptor binding.
that described for any other receptor system. One level
of interaction involves the selective modulation of Trk/
neurotrophin binding affinity. p75NTR enhances the affin-contain small amounts of proneurotrophins (Reinshagen
ity of TrkA for NGF, while decreasing affinity for NT-3.et al., 2000; Lee et al., 2001) and the extent of this con-
Similarly, p75NTR differentially modulates the interactionstamination is likely to vary from source to source and
of TrkB for BDNF, NT-3, and NT-4/5 (Bibel et al., 1999).from batch to batch. Thus, the extent to which neuro-
Several models have been used to explain the genera-trophins activate p75-mediated responses may be influ-
tion of high-affinity NGF binding sites through functionalenced by the amount of proneurotrophins in each prepa-
collaboration of p75NTR and TrkA, one suggesting a pre-ration.
sentation of ligand by p75NTR to the Trk receptor and theIt remains to be established whether pro-forms of
second involving conformational changes in the recep-BDNF, NT-3, and NT-4/5 also have enhanced affinity for
tors that facilitates binding of ligand (Figure 2). Recent
p75 receptors and reduced affinity for TrkB and TrkC,
evidence has argued against a presentation model in
relative to the mature forms of these neurotrophins. This
favor of a conformational change in the Trk receptor
possibility is anticipated since a fraction of each neuro-
(Esposito et al., 2001). These conformational changes
trophin is secreted as the proneurotrophin. Furthermore, are dependent upon transmembrane domain interac-
one region of the pro-domain is conserved among all tions between the receptors. Similar mechanisms may
neurotrophins, possibly representing a shared binding account for effects of p75NTR on TrkB.
site for p75NTR. The survival of a cell possessing both p75NTR and Trk
Implications for Neurotrophin Receptors receptors may be determined by the ratio of these two
One consequence of the binding results reported by Lee receptors and by the relative affinity for neurotrophin
et al. (2001) is that the distinction between “high-affinity” binding to the two receptors. The discovery that NGF
and “low-affinity” neurotrophin receptors has become may be secreted as proNGF, which preferentially acti-
blurred. Historically, p75NTR and Trk receptors have been vates p75NTR, or as mature NGF, which preferentially
referred to as low- and high-affinity receptors, respec- activates TrkA, suggests that the balance between cell
tively. This designation was never entirely appropriate, death and cell survival may be determined by the ratio
since high-affinity NGF binding sites can be formed by of proNGF and mature NGF secreted by biosynthetic
the functional collaboration of p75 and TrkA receptors cells. For example, activation of TrkA receptors can ne-
that individually possess lower (109 M Kd) affinities for gate the proapoptotic effect of p75NTR (Yoon et al., 1998).
NGF binding (Hempstead et al., 1991), and p75 receptors In agreement with the predictions of this model, Lee et
in some cell types bind NT-3 with a Kd in the picomolar al. (2001) demonstrated that proNGF induces apoptosis
range (Dechant and Barde, 1997). The discovery that of sympathetic neurons, presumably because, unlike
p75NTR binds proNGF with an affinity similar to the high- mature NGF, it activates p75 without activating TrkA.
est affinity reported for NGF/TrkA interactions renders The potential for extracellular proteases to convert
entirely obsolete the designation of p75NTR and TrkA as proNGF to a form resembling the mature product of
low- and high-affinity receptors. intracellular processing adds additional dimensions to
The essence of the neurotrophic hypothesis is that this model. Lee et al. (2001) demonstrate that both
neurons avoid programmed cell death by competition proNGF and proBDNF are avidly processed by several
for scarce quantities of trophic factors such as neuro- proteases including plasmin and specific matrix metallo-
proteinases. Matrix metalloproteinases exist both astrophins. Therefore, the generation of high-affinity neu-
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Figure 2. Different Models of Trk and p75
Neurotrophin Receptor Interactions
Neurotrophins can activate Trk receptors in-
dependently, resulting in autophosphoryla-
tion and activation of adaptor proteins, in-
cluding SHC, FRS-2, PLC-. The p75 receptor
alone can also mediate signaling through
each neurotrophin. When TrkA receptors are
coexpressed with p75NTR, a new kinetic site
is formed that exhibits high-affinity binding
properties. p75NTR can increase the binding
affinity of NGF, either by passing the ligand
to the Trk receptor, or altering the conforma-
tion of TrkA receptors through allosteric inter-
actions (see Esposito et al., 2001).
transmembrane proteins and as extracellular matrix an- Under similar conditions, there is also increased p75NTR
expression. For example, following seizure, there ischored proteins. Thus, they are suitably positioned to
modify proneurotrophins as they are secreted, or as prominent expression of p75NTR in cortical neurons (Roux
et al., 1999). Induction of p75NTR in oligodendrocytes,they associate with responsive cells.
The existence of multiple mechanisms to regulate microglia, and macrophages has also been observed in
multiple sclerosis (Chang et al., 2000) and in epilepsyNGF activation of p75NTR or TrkA receptors is likely to
have widespread importance, since the majority of NGF- (M.B., unpublished data). The observation that NGF ex-
ists almost exclusively in the form of proNGF in humanresponsive neurons, including sensory, sympathetic,
and basal forebrain cholinergic neurons, express both brain suggests that activation of p75NTR may be of partic-
ular importance. Especially intriguing are the observa-p75NTR and TrkA. Such considerations may possess less
relevance for other neurotrophins, since only a fraction tions that proNGF levels are elevated in postmortem
samples of parietal cortex from Alzheimer’s patientsof the various neuronal populations expressing TrkB and
TrkC also express p75NTR. (Fahnestock et al., 2001) and that plasmin is diminished
in Alzheimer’s brain (Ledesma et al., 2000), raising theImplications for Development and Disease
The ability of proNGF to kill cells is unexpected and has possibility that p75NTR activation may contribute to dis-
ease pathology.broad implications for a number of biological problems.
During development, elimination of neurons by trophic The functional significance of proneurotrophins may
not be restricted to trophic interactions as BDNF isfactor deprivation is a predominant mechanism for con-
trolling cell number. However, p75NTR signaling also may known to play an important role in synaptic function.
BDNF is secreted via a regulated secretory pathwayinitiate a killing process during development. This has
been documented in sympathetic neurons by BDNF by which synaptic activity causes perisynaptic BDNF
release. Synaptically released BDNF acting on TrkB re-(Bamji et al., 1998) and in the developing eye and spinal
cord by NGF (Frade and Barde, 1999). It has been sug- ceptors enhances synaptic transmission and contrib-
utes to other forms of synaptic plasticity (Poo, 2001).gested that cell death may occur through p75 action in
each of the various neuron types expressing p75NTR if a The majority of BDNF secreted by a variety of cell types,
including pituitary neurosecretory cells and hippocam-Trk receptor and its cognate neurotrophin (TrkA/NGF;
TrkB/BDNF; TrkC/NT-3) are not appropriately expressed pal neurons, is released in the form of proBDNF (Mowla
et al., 2001). Thus, postsecretory proteolytic processingby the neuron and its target (Majdan and Miller, 1999).
Proneurotrophins may use p75 as a death receptor to may be essential for efficient TrkB receptor activation.
Lee et al. (2001) established that proBDNF is cleavedprune neurons during periods of developmental pro-
grammed cell death. During target innervation, cells may by selective enzymes, such as plasmin, and the matrix
metalloproteinase MMP-7 but not MMP-2 or MMP-3.undergo apoptosis if the proper set of trophic factors
is not encountered. In this case, a proneurotrophin may Intriguingly, tissue plasminogen activator, like BDNF, is
important for hippocampal long-term potentiation (Bar-bind to p75 and eliminate cells by an active killing pro-
cess. Hence, the processing of proneurotrophins may anes et al., 1998). Regulation of the activity of plasmin,
MMP-7 and other proteases may be an important meansrepresent a critical decision making step to ensure neu-
ronal survival during certain developmental windows. of regulating synaptic activities of proBDNF and other
proneurotrophins. These proposed cleavages and theirActivation of p75NTR by proneurotrophins may provide
other functions to promote cell migration or even cell impact on trophic and synaptic activities need to be
further explored and verified in physiologically relevantsurvival through pathways involving increased NFB or
c-jun kinase activities. These signaling functions for situations.
The differential ability of proNGF and mature NGF toproneurotrophins may be especially important during
physiological conditions of stress or injury. Upregulation bind selective receptors and mediate distinctive biologi-
cal actions is unique at present. However, many otherof neurotrophins is observed under pathological or in-
flammatory conditions, particularly after nerve injury and growth factors and ligands in the nervous system are
made as larger precursor proteins and cleaved intodamage to the vascular system (Donovan et al., 1995).
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smaller forms. This includes the neuregulins, agrin, and
members of the GDNF, HB-EGF, TGF-, and TGF- fam-
ilies. Many of these precursor proteins are found associ-
ated with the extracellular matrix or plasma membrane
and are subsequently cleaved to release biologically
active mature forms. Furthermore, these proteins and
the extracellular proteases that regulate their proteolysis
are frequently increased during neuronal injury, neuro-
degeneration, and inflammation. Further characteriza-
tion of the specific proteases, their patterns of expres-
sion, and their receptor specificities will provide new
insights into growth factor action during normal and
pathophysiological conditions.
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